IOVANCE BIOTHERAPEUTICS, INC. Interest Expense
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Interest Expense of -$5.66 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2015-03-16
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for the quarter ending 2014-12-31 was -$1.47K.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for the quarter ending 2014-09-30 was -$4.19K.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for fiscal 2014 was -$5.66K, a 101.27% decline from fiscal 2013.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for fiscal 2013 was $444.73K, a 76.86% decline from fiscal 2012.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for fiscal 2012 was $1.92M, a 1168.63% increase from fiscal 2011.
- IOVANCE BIOTHERAPEUTICS, INC. interest expense for fiscal 2011 was $151.51K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 48 month | Interest Expense 51 month | Interest Expense 54 month | Interest Expense 57 month | Interest Expense 60 month | Interest Expense 63 month | Interest Expense 66 month | Interest Expense 69 month | Interest Expense 72 month | Interest Expense 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$1.47K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$5.66K derived: sum of 2 quarters · filed 2015-03-16 | -$5.66K derived: sum of 3 quarters · filed 2015-03-16 | -$5.66K 10-K · filed 2015-03-16 | ||||||||||||
| 2014-09-30 | -$4.19K 10-Q · filed 2014-11-13 | -$4.19K derived: sum of 2 quarters · filed 2014-11-13 | -$4.19K 10-Q · filed 2014-11-13 | -$5.20K derived: sum of 4 quarters · filed 2015-03-16 | ||||||||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | -$1.01K derived: sum of 3 quarters · filed 2015-03-16 | -$1.01K derived: sum of 4 quarters · filed 2015-03-16 | ||||||||||||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2015-03-16 | -$1.01K derived: sum of 2 quarters · filed 2015-03-16 | -$1.01K derived: sum of 3 quarters · filed 2015-03-16 | $103.11K derived: sum of 4 quarters · filed 2015-03-16 | $2.52M 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | -$1.01K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$1.01K derived: sum of 2 quarters · filed 2015-03-16 | $103.11K derived: sum of 3 quarters · filed 2015-03-16 | $444.73K 10-K · filed 2015-03-16 | ||||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $104.13K derived: sum of 2 quarters · filed 2014-11-13 | $445.74K 10-Q · filed 2014-11-13 | $2.04M derived: sum of 4 quarters · filed 2014-11-13 | $2.52M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $104.13K 10-Q · filed 2014-08-08 | $445.74K 10-Q · filed 2014-08-08 | $2.04M derived: sum of 3 quarters · filed 2014-08-08 | $2.17M derived: sum of 4 quarters · filed 2014-08-08 | $2.52M 10-Q · filed 2013-10-23 | |||||||||||
| 2013-03-31 | $341.62K 10-Q · filed 2014-05-14 | $1.94M derived: sum of 2 quarters · filed 2014-05-14 | $2.06M derived: sum of 3 quarters · filed 2014-05-14 | $2.17M derived: sum of 4 quarters · filed 2014-05-14 | $2.41M 10-Q · filed 2013-10-23 | |||||||||||
| 2012-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $1.72M derived: sum of 2 quarters · filed 2013-11-14 | $1.83M derived: sum of 3 quarters · filed 2013-11-14 | $1.92M 10-K · filed 2013-09-23 | $2.07M 10-K · filed 2013-09-23 | |||||||||||
| 2012-09-30 | $126.92K 10-Q · filed 2013-11-14 | $237.73K derived: sum of 2 quarters · filed 2013-11-14 | $326.56K 10-Q · filed 2013-11-14 | $446.07K derived: sum of 4 quarters · filed 2013-11-14 | $477.71K 10-Q · filed 2013-01-25 | |||||||||||
| 2012-06-30 | $110.81K 10-Q · filed 2013-10-23 | $199.28K 10-Q · filed 2013-10-23 | $319.14K derived: sum of 3 quarters · filed 2013-10-23 | $350.79K derived: sum of 4 quarters · filed 2013-10-23 | $350.79K 10-Q/A · filed 2012-09-10 | |||||||||||
| 2012-03-31 | $88.47K 10-Q · filed 2013-10-23 | $208.34K derived: sum of 2 quarters · filed 2013-10-23 | $239.98K derived: sum of 3 quarters · filed 2013-10-23 | $239.98K 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $119.86K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | $151.51K derived: sum of 2 quarters · filed 2013-09-23 | $151.51K 10-K · filed 2013-09-23 | $151.51K 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | $31.64K 10-Q · filed 2013-01-25 | -$31.64K 10-Q · filed 2011-11-21 | $31.64K 10-Q · filed 2013-01-25 | -$31.64K 10-Q · filed 2011-11-21 | -$31.64K 10-Q · filed 2011-11-21 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | $0.00 derived: sum of 2 quarters · filed 2012-05-15 | $0.00 derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $0.00 derived: sum of 2 quarters · filed 2012-03-30 | $0.00 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-21 | $0.00 10-Q · filed 2011-11-21 | ||||||||||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |